Valita Titer Assay vs. Traditional IgG Measurement Technologies
The accurate, rapid and high-throughput measurement of immunoglobulin G (IgG) is essential in the development and subsequent manufacture of therapeutic antibodies.
However, with some IgG measurement methods—such as ELISA and Protein A HPLC—it may take hours to obtain results due to tedious sample prep and the need for multiple reagents. And when you’re processing hundreds or thousands of clones to generate a commercially viable cell line, those hours add up and add unnecessary complexity to your workflow.
With the Valita Titer assay, there’s no sample prep, additional reagents or wash required. Because of that, you’ll be able to prepare and measure a full 96- or 384-well plate in as little as 15 minutes.
Comparison of Analysis Attributes
Available in 96- and 384-well plate formats, and in two detection range formats—2.5 – 100 mg/L and 100 -2000 mg/L— the Valita Titer assay enables rapid, high-throughput IgG quantification directly from crude cell culture samples. The charts below compare IgG quantification in crude culture samples using the Valita Titer assay, biolayer interferometry (BLI), Protein A HPLC and ELISA.
Insightful Resources
Rapid Rabbit IgG Quantification using the Valita Titer Assay
Valita Titer Assay Brochure
Increased throughput for IgG quantification using Valita Titer 384-well plates
Automating the Valita Titer IgG Quantification Assay on a Biomek i-Series Liquid Handling System
Learn More About the Valita Titer Assay
Introducing Valita Titer Assays
Valita Titer plate-based, 96- and 384-well assays that offer a rapid, cost-effective way to measure IgG
Automate With Ease
Easily integrate Valita Titer into your automated liquid handler and microplate reader
Cell Line Development Webinar
Speed up your clone selection process with the Valita Titer assay
Say Goodbye to Sample Preparation
Measure IgG titer straight from cell culture samples—no sample prep, additional reagents or wash required
Future of Bioprocessing
Let's dive into the world of monoclonal antibodies and explore the solutions that pave the way for innovative and effective therapeutics.